Lung Cancer Screening Programs Near Sun City, FL
Moffitt Cancer Center provides a comprehensive range of lung cancer screening services near Sun City, Florida. With three locations for screening exams in nearby Tampa, Moffitt makes it easy for at-risk individuals (including current and former smokers) to be proactive in monitoring their health. By administering routine imaging scans and physical exams, we help patients detect abnormal changes as early as possible, when survival outcomes and quality of life are typically the most favorable.
The primary test used for lung cancer screening is a high-definition CT scan, the result of which can show even the smallest changes in a patient’s lung tissue. If a potential tumor is detected, additional testing can then be performed to determine if the abnormality is cancerous. (In some cases, screenings produce a “false positive” result, in which no cancerous changes are present, despite an abnormal finding on a patient’s CT scan).
At Moffitt, each patient’s screening is performed by a highly experienced oncologist who can also provide:
- Risk-reduction recommendations
- Smoking cessation assistance
- An individualized schedule for future screenings
- Follow-up testing, such as additional imaging scans or tissue biopsies
Screening results are evaluated by a collaborative team of experts. In the event that a lung cancer diagnosis is made, patients can also discuss their treatment options with our highly regarded oncologists and pulmonologists. Moffitt provides a full scope of services, from preventive screenings and diagnostic services to surgery, radiation therapy, chemotherapy and novel treatments, all under one roof. We are located just a short drive away from Sun City and are one of the nearest Lung Cancer Alliance Screening Centers of Excellence.
For more information about Moffitt’s lung cancer screening program, call 1-888-663-3488 or submit a new patient registration form online. We welcome patients from Sun City, FL, with or without physicians’ referrals.
Lung Cancer
- Adrenal Cancer
- Anal Cancer
- Appendiceal (Appendix) Cancer
- Astrocytoma
- Basal Cell Carcinoma
- Bladder Cancer
- Bone Metastasis
- Brain Cancer
- Brain Tumor
- Breast Cancer
- Cervical Cancer
- Cholangiocarcinoma (Bile Duct Cancer)
- Colon Cancer
- Colorectal Cancer
- Cutaneous T-Cell Lymphoma
- Ductal Carcinoma In Situ
- Endometrial (Uterine) Cancer
- Esophageal Cancer
- Gallbladder Cancer
- Gastrointestinal Carcinoid Tumor
- GIST (Gastrointestinal Stromal Tumor)
- Glioblastoma
- Head and Neck Cancer
- HER2 Positive Breast Cancer
- Hodgkin Lymphoma
- Inflammatory Breast Cancer
- Invasive Ductal Carcinoma
- Kidney (Renal Cell) Cancer
- Leukemia
- Liver (Hepatocellular) Cancer
- Low-Grade Glioma
-
Lung Cancer
- Signs and Symptoms
- Diagnosis
- Treatment
- FAQs
- Lung Cancer Early Detection Center
- Lung Cancer Screening and Surveillance Program
- Lung Nodules
- Lung Surveillance Clinic
- Metastatic Lung Cancer
- Recurrence
- Survival Rate
- Your Lung Cancer Specialists
- Lung and Thoracic Tumor Education (LATTE)
- Thoracic Clinic Updates
- Insurance & Financial Information
- Lymphomas (Hodgkin and Non-Hodgkin)
- Melanoma
- Meningioma
- Merkel Cell Carcinoma
- Mesothelioma
- Metastatic Breast Cancer
- Multiple Myeloma-Plasma Cell Tumor
- Myelodysplastic Syndromes (MDS)
- Neuroendocrine Tumor
- Neurofibromatosis
- Non-Hodgkin Lymphoma
- Oral Cavity (Mouth) Cancer
- Oral Cavity or Throat Cancer
- Osteosarcoma
- Ovarian Cancer
- Pancoast Tumor
- Pancreatic Cancer
- Penile Cancer
- Pituitary Adenoma
- Prostate Cancer
- Rectal Cancer
- Sarcoma
- Skin Cancer (Nonmelanoma)
- Skull Base Tumors
- Small Intestine Cancer
- Spinal Tumor
- Squamous Cell Carcinoma
- Stomach (Gastric) Cancer
- Testicular Cancer
- Throat Cancer
- Thymoma
- Thyroid Cancer
- Tongue Cancer
- Tracheal Cancer
- Triple Negative Breast Cancer
- Vaginal Cancer
- Vulvar Cancer